Oric Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

ORIC Pharmaceuticals

10/05/2022 22:02

* Oric Pharmaceuticals Inc  ORIC.OQ  reported a quarterly
adjusted
loss of 59 cents​​ per share for the quarter ended in March. The
mean expectation of seven analysts for the quarter was for a
loss of 57 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Oric Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 59 cents​.
    * The mean earnings estimate of analysts had risen by
about 6% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Oric Pharmaceuticals Inc shares had fallen by 49.4% this
quarter and lost 81.6% so far this year.
    * The company reported a quarterly loss of $23.16 million.
    * Wall Street's median 12-month price target for Oric
Pharmaceuticals Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated